InnoCare Pharma Limited 諾誠健華醫藥有限公司

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chen, Kaixian 陳凱先 INED
2 Cui, Jisong 崔霽松 Ch, CEO 4,247 3,240 16 7,503
3 Fu, Shan 付山 NED
4 Hu, Lan (1971) 胡蘭 INED
5 Jin, Ming (1973) 金明 NED
6 Shi, Yigong (1967) 施一公 NED
7 Xie, Ronggang 謝榕剛 NED
8 Yuan, Quanhong 苑全紅 NED
9 Zhang, Jason Zemin 張澤民 INED
10 Zhao, Renbin 趙仁濱 ED 2,162 648 96 2,906
Total 0 6,409 3,888 96 16 10,409

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 985 7,479 4,375 86 11,886 24,811 Report
2023-12-31 800 7,254 4,579 69 14,779 27,481 Report
2022-12-31 0 6,409 3,888 96 16 10,409 Report
2021-12-31 38 4,469 2,304 90 24 6,925 Report
2020-12-31 863 3,659 0 39 130 4,691 Report
2019-12-31 294 3,799 0 88 31 4,212 Report
Total 2,980 33,069 15,146 468 26,866 78,529

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top